Trials / Completed
CompletedNCT04799509
Assessment of the 90-day Mortality Risk Score After VATS Lobectomy
Assessment of the 90-day Mortality Risk Score After Video-assisted Thoracoscopic Lobectomy in the Italian VATS Group Cohort
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,209 (actual)
- Sponsor
- Università degli Studi dell'Insubria · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
A five classes (A-E) aggregate risk score predicting 90-day mortality after video-assisted thoracoscopic lobectomy for lung cancer, including as independent factors male sex (3 points), carbon monoxide lung diffusion capacity \<60% (1 point) and operative time \>150 minutes (1 point), has been recently published. This study aims to assess the effectiveness and reliability of this risk model in a large, independent cohort of patients, in order to confirm its generalizability.
Detailed description
From the Italian VATS Group Database, we selected patients who underwent video-assisted thoracoscopic lobectomy for non-small cell lung cancer. We calculated the aggregate risk score and the corresponding class of 90-day mortality risk for each patient. The correlation between risk classes and mortality rates was tested by Spearman's rho-test. Model calibration was evaluated by Hosmer-Lemeshow goodness-of-fit test.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | VATS lobectomy | VATS lobectomy |
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2018-11-27
- Completion
- 2018-11-27
- First posted
- 2021-03-16
- Last updated
- 2021-03-22
Source: ClinicalTrials.gov record NCT04799509. Inclusion in this directory is not an endorsement.